Zobrazeno 1 - 10
of 143
pro vyhledávání: '"MA Mouret"'
Autor:
S Lavau, S Duros, AS Gremeau, C. Palpacuer, F Leperlier, C. Lefeuvre-Plesse, P De Blay, S Mirallie, Paule Augereau, LM Durand, MA Mouret, F Delay, C Frick, V Bordes, M. Campone, A Dezellus, B Sauterey
Publikováno v:
Cancer Research. 79:P4-16
Background: Breast cancer is the most frequent form of cancer in young women. For these patients, breast cancer is generally more aggressive and chemotherapy is more often needed. Chemotherapy is commonly associated with amenorrhea and a decrease of
Autor:
Ma, Mouret-Reynier, Abrial C, Leheurteur M, Durando X, Van Praagh I, Gimbergues P, Jl, Achard, Jp, Ferrière, Cure H, philippe chollet
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8bf1a5c937d2c5d1ab68a8c10c271f7e
http://europepmc.org/abstract/med/17145582
http://europepmc.org/abstract/med/17145582
Autor:
Emilie THIVAT, Mc, Farges, Bacin F, D'Incan M, Ma, Mouret-Reynier, Cellarier E, Jc, Madelmont, Mp, Vasson, Chollet P, Durando X
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1b567c94fb53827a48130cbda802c967
http://europepmc.org/abstract/med/20044642
http://europepmc.org/abstract/med/20044642
Autor:
Piffoux M; Hospices Civils de Lyon, lyon, France., Jacquemin J; Centre Léon Bérard, Lyon, France., Pétéra M; INRAE, Clermont-Ferrand, France., Durand S; University of Clermont Auvergne, St Genes Champanelle, France., Abila A; University of Clermont Auvergne, CLERMONT-FERRAND, France., Centeno D; University of Clermont Auvergne, France., Joly C; University of Clermont Auvergne, Clermont-fd, France., Lyan B; University of Clermont Auvergne, France., Martin AL; UNICANCER, Paris, France., Everhard S; UniCancer Group, Paris, France., Boyault S; Centre Leon Berard, Lyon, France., Pistilli B; Institut Gustave Roussy, Villejuif, France., Fournier M; Institut Bergonié, France., Rouanet P; Institut Regional du Cancer de Montpellier, montpellier, France., Havas J; Institut Gustave Roussy, villejuif, France., Sauterey B; Institut de Cancérologie de l'Ouest, angers, France., Campone M; ICO, Saint-Herblain, France., Tarpin C; Institute Paoli-Calmettes, Marseille, France., Mouret-Reynier MA; Centre Jean Perrin, clermont ferrand, France., Rigal O; Centre Henri Becquerel, Rouen, France., Petit T; Institut de Cancérologie Strasbourg, France., Lasset C; Centre Léon Bérard, Lyon, France., Bertaut A; Centre Georges François Leclerc, Dijon, France., Cottu P; Institute Curie, Paris, France., Andre F; Institut Gustave Roussy, villejuif, France., Vaz-Luis I; Institut Gustave Roussy, Villejuif, France., Pujos-Guillot E; Clermont Auvergne University, INRAE, Clermont-Ferrand, France., Drouet Y; Centre Léon Bérard, Université de Lyon, CNRS UMR 5558 LBBE, Lyon, France., Trédan O; Centre Leon Berard, Lyon, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 06. Date of Electronic Publication: 2024 Aug 06.
Autor:
Le Saux O; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France., Ardin M; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Berthet J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Bourhis M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Cinier J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Lounici Y; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Treilleux I; Department of Anatomopathology, Centre Léon Bérard, 69008, Lyon, France., Just PA; Department of Anatomopathology, AP-HM, Marseille, France., Bataillon G; Department of Anatomopathology, University hospital of Toulouse, Toulouse, France., Savoye AM; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Mouret-Reynier MA; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Coquan E; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre François Baclesse, Caen, France., Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France., Jeay L; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Bouizaguen S; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Labidi-Galy I; Department of Oncology, Hôpitaux universitaires de Genève, Faculty of Medecine, Center of Translational Research in Onco-Hematology, Swiss Cancer Center Leman, Geneva, Switzerland., Tabone-Eglinger S; Human Biological Resources, Centre Léon Bérard, 69008, Lyon, France., Ferrari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Thomas E; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Ménétrier-Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Tartour E; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Galy-Fauroux I; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005, Paris, France., Terme M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Dubois B; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr., Ray-Coquard I; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France. isabelle.ray-coquard@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5932. Date of Electronic Publication: 2024 Jul 16.
Autor:
Ray-Coquard IL; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr., Savoye AM; GINECO and Institut Jean Godinot, Reims, France., Schiffler C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France., Mouret-Reynier MA; GINECO and Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Derbel O; GINECO and Institut de Cancérologie, Hôpital Privé Jean Mermoz, Lyon, France., Kalbacher E; GINECO and Centre Hospitalier Universitaire Jean Minjoz, Besançon, France., LeHeurteur M; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France., Martinez A; GINECO and Institut Claudius Régaud, Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France., Cornila C; GINECO and Centre Hospitalier Régional d'Orléans, Orleans, France., Martinez M; GINECO and Clinique Pasteur, Toulouse, France., Bengrine Lefevre L; GINECO and Centre Georges-François Leclerc, Dijon, France., Priou F; GINECO and Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France., Cloarec N; GINECO and Centre Hospitalier Henri Duffaut d'Avignon, Avignon, France., Venat L; GINECO and Centre Hospitalier Universitaire Dupuytren, Limoges, France., Selle F; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Berton D; GINECO and Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Collard O; GINECO and Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, France.; Center of Medical Oncology, Hôpital Privé de la Loire, Saint-Etienne, France., Coquan E; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France., Le Saux O; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France.; Cancer Research Center of Lyon (CRCL), UMR INSERM 1052, Centre Léon Bérard, CNRS 5286, Lyon, France., Treilleux I; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France., Gouerant S; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France., Angelergues A; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Joly F; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France., Tredan O; GINECO and Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5931. Date of Electronic Publication: 2024 Jul 16.
Autor:
Dezellus A; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France. Electronic address: aliette.dezellus@ico.unicancer.fr., Mirallie S; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Nantes, France., Leperlier F; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Nantes, France., Sauterey B; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France., Bouet PE; Service de Médecine et Biologie du Développement et de la Reproduction, CHU Angers, France., Dessaint A; Centre Eugène Marquis, Rennes, France., Duros S; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Rennes, France., Gremeau AS; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Clermont-Ferrand, France., Mouret-Reynier MA; Centre Jean Perrin, Clermont-Ferrand, France., Durand LM; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Limoges, France., Venat L; Service d'oncologie, CHU de Limoges, France., De Blay P; Service de Gynécologie-Obstétrique CH de Vendée, La Roche-sur-Yon, France., Robert M; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France., Freour T; Service de Médecine et Biologie du Développement et de la Reproduction, CHU de Nantes, France., Campone M; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France; Université Nantes/Angers, Inserm, CNRS, CRCI2NA, France., Blanc-Lapierre A; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France., Bordes V; Institut de Cancérologie de l'Ouest, Saint Herblain et Angers, France.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2024 Oct; Vol. 77, pp. 103776. Date of Electronic Publication: 2024 Aug 03.
Autor:
Ginzac A; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France. angeline.ginzac@clermont.unicancer.fr.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr., Molnar I; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Durando X; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Motte Rouge T; Service d'oncologie médicale, Centre Eugène MARQUIS, Rennes, France., Petit T; Service d'oncologie médicale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., D'hondt V; Service d'oncologie médicale, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Campone M; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Bonichon-Lamichhane N; Service d'oncologie médicale et radiothérapie, Clinique Tivoli, Bordeaux, France., Venat Bouvet L; Service d'oncologie médicale, CHU Dupuytren, Limoges, France., Levy C; Service d'oncologie médicale, Centre François BACLESSE, Caen, France., Augereau P; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Pistilli B; Service d'oncologie médicale, Institut Gustave ROUSSY, Villejuif, France., Arsene O; Service d'oncologie médicale, Centre Hospitalier de Blois, Blois, France., Jouannaud C; Service d'oncologie médicale, Institut Jean GODINOT, Reims, France., Nguyen S; Service d'oncologie médicale, Centre Hospitalier de Pau, Pau, France., Cayre A; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Tixier L; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mahier Ait Oukhatar C; Unicancer, Paris, France., Nabholtz JM; Centre d'oncologie, Université King Saud (Medical City), Riyadh, Arabi Saoudite., Penault-Llorca F; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mouret-Reynier MA; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 267-279. Date of Electronic Publication: 2024 Mar 07.
Autor:
Roussot N; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; INSERM U1231, 21000 Dijon, France., Constantin G; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France., Desmoulins I; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Bergeron A; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France., Arnould L; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France., Beltjens F; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France., Mayeur D; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Kaderbhai C; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Hennequin A; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Jankowski C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Padeano MM; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Costaz H; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Jacinto S; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Michel E; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Amet A; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Coutant C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; University of Burgundy-Franche Comté, 21000 Dijon, France., Costa B; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Jouannaud C; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Deblock M; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Kerbrat P; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Brain E; Department of Medical Oncology, Institut Curie, Centre René Huguenin, Saint-Cloud, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Coudert B; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France., Bertaut A; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France., Ladoire S; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; University of Burgundy-Franche Comté, 21000 Dijon, France; INSERM U1231, 21000 Dijon, France. Electronic address: sladoire@cgfl.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 114037. Date of Electronic Publication: 2024 Mar 26.
Autor:
Epaillard N; Department of Medical Oncology, Gustave Roussy, Villejuif. Electronic address: Nicolas.epaillard@gmail.com., Lusque A; Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT Oncopole, Toulouse., Jacot W; Department of Medical Oncology, Institut régional du Cancer, Montpellier., Mailliez A; Department of Medical Oncology, Centre Oscar Lambret, Lille., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon., Arnedos M; Department of Medical Oncology, Institut Bergonié, Bordeaux., Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Rennes., Brain E; Department of Medical Oncology, Institut Curie, Saint-Cloud., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice., Massard V; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy., Desmoulins I; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen., Gonçalves A; Department of Medical Oncology, Institut Paoli Calmette, Marseille., Leheurteur M; Department of Medical Oncology, Centre Henri Becquerel, Rouen., Petit T; Department of Medical Oncology, Centre Paul Strauss ICANS, Strasbourg., Filleron T; Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT Oncopole, Toulouse., Bosquet L; Health Data and Partnership Department, Unicancer, Paris., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif; INSERM U1279, Gustave Roussy, Villejuif., Frenel JS; Department of Medical Oncology, Institut de Cancerologie de L'Ouest, Saint-Herblain, France.
Publikováno v:
ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103447. Date of Electronic Publication: 2024 May 03.